Sulphonylureas in the treatment of non-insulin-dependent diabetes (Q39578390)

13 September 2017

1 reference

title

Sulphonylureas in the treatment of non-insulin-dependent diabetes (English)

1 reference

13 September 2017

1 reference

Melander A

1

1 reference

PubMed ID

3075901

13 September 2017

language of work or name

1 reference

1 May 1988

1 reference

Bailliere's clinical endocrinology and metabolism

13 September 2017

1 reference

13 September 2017

2

1 reference

13 September 2017

2

1 reference

13 September 2017

443-453

1 reference

Glibenclamide-associated hypoglycaemia: a report on 57 cases

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Assessment of laboratory methods for detection of unsuspected diabetes in primary health care.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Efficacy of dietary regulation in primary health care patients with hyperglycaemia detected by screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Interaction of ethanol and glipizide in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in β-cell-rich pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

A role for insulin in the aetiology and course of hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Glucose and Insulin Secretory Response Patterns Following Diet and Tolazamide Therapy in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

Impaired effect of sulfonylurea following increased dosage.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980042-9

7 January 2021

10.1016/S0950-351X(88)80042-9

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

3075901